Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignant melanoma].

Kazuhiko Matsumoto1, Toshiaki Saida

  • 1Clinical Trial and Research Center, Shinshu University Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 15, 2006
PubMed
Summary

High-dose interferon-alpha (IFNalpha) shows potential for improving disease-free survival in high-risk melanoma patients, but its severe toxicity remains a concern. Research explores alternative therapies like interferon-beta (IFNbeta) for better melanoma treatment outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrochemically Induced Interphase by Complex Hydride Anions in Argyrodite Solid Electrolytes for Stable Lithium Metal All-Solid-State Batteries.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Probing Hidden Phase Transitions in Plastic Crystal Succinonitrile.

The journal of physical chemistry letters·2026
Same author

Seasonal variation in particulate organic carbon sequestration in subarctic and subtropical gyres of the western North Pacific.

Scientific reports·2026
Same author

An observational case study for inorganic nitrogen dry deposition potential on sea-surface primary production in the subtropical, western North Pacific.

Scientific reports·2026
Same author

Intra-patient neuraminidase mutations in avian H5N1 influenza virus reduce sialidase activity to complement weaker hemagglutinin binding and facilitate human infection.

PLoS pathogens·2026
Same author

Enthalpy-Entropy Compensation Governs the Solvent-Mixing Effect in Electrochemical Thermoelectric Conversion.

Journal of the American Chemical Society·2026

Area of Science:

  • Oncology
  • Immunotherapy
  • Melanoma Research

Context:

  • High-risk melanoma patients often receive adjuvant therapy post-surgery.
  • Interferon-alpha (IFNalpha) has been extensively studied as a post-surgical adjuvant therapy.
  • The efficacy and toxicity of high-dose IFNalpha (HDI) and low-dose IFNalpha (LDI) are subjects of ongoing debate.

Purpose:

  • To evaluate the effectiveness of different interferon-based therapies for melanoma.
  • To explore the role of interferon-beta (IFNbeta) in combination with chemotherapy for stage III melanoma.
  • To assess the safety and efficacy of novel IFNbeta gene therapy for advanced melanoma.

Summary:

  • Prospective randomized clinical trials investigated IFNalpha for high-risk melanoma, with HDI showing disease-free survival (DFS) benefits but significant toxicity.
  • LDI demonstrated inconsistent effects on DFS and limited activity in metastatic melanoma.
  • In Japan, IFNbeta combined with chemotherapy is used for stage III melanoma, and a phase I/IIa trial of IFNbeta gene therapy for advanced melanoma was recently conducted.

Impact:

  • Findings contribute to understanding the complex role of interferons in melanoma adjuvant therapy.
  • Highlights the need for balancing treatment efficacy with patient safety and tolerability.
  • Paves the way for exploring novel immunotherapeutic strategies, including gene therapy, for advanced melanoma.

Related Experiment Videos